ResMed | RMD - Market Capitalization


ResMed reported $29.21B in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Ansell USD 3.36B 450.92M Dec/2025
Artivion USD 2.18B 176M Dec/2025
AtriCure USD 1.44B 522M Mar/2026
Baxter International USD 8.67B 1.15B Mar/2026
Cochlear AUD 17.05B 2.6B Dec/2025
Cooper Companies USD 12.27B 3.68B Mar/2026
CSL USD 55.89B 20.42B Dec/2025
Dexcom USD 24.17B 1.72B Mar/2026
Edwards Lifesciences USD 46.17B 3.3B Mar/2026
Fisher Paykel Healthcare NZD 22.6B 636.38M Jul/2026
Globus Medical USD 11.69B 2M Mar/2026
Idexx Laboratories USD 44.63B 9.39B Mar/2026
Insulet USD 14.53B 5.46B Mar/2026
Integra LifeSciences USD 733M 234M Mar/2026
Intuitive Surgical USD 141.97B 21.76B Jul/2026
Philips EUR 22.47B 96.29M Mar/2026
Ramsay Health Care AUD 7.93B 537.83M Dec/2025
ResMed USD 32.7B 2.46B Mar/2026
Sigma Healthcare AUD 2.7B 1.98B Jul/2026
Sonic Healthcare AUD 11.17B 1.7B Dec/2025
Steris USD 21.69B 3.2B Mar/2026
Teleflex USD 5.3B 99M Mar/2026
Thermo Fisher Scientific USD 182.66B 35.04B Mar/2026